This site is intended for Healthcare Professionals only.

West Lothian village gets second pharmacy

Date:

Share post:

Blackburn in West Lothian, Scotland is set to welcome a second pharmacy.

“A further action within the Blackburn’s Future Plan that came from the consultation carried out within the community was the need for an additional pharmacist,” local regeneration officer Michelle Kirkbright said in a report to a recent meeting of the Whitburn and Blackburn Local Area Committee.

“This information was used to help strengthen the application for a new pharmacist in Blackburn which resulted in the application being successful. The new ‘Blackburn Pharmacy’ will be based within the Mill Centre and will provide additional services to the community.

“The pharmacist is also hoping to employ staff from the Blackburn area.”

A sub group of Blackburn Futures Group (BFG), led by the community council, has been working on proposals for economic development in the village, amid speculation surrounding the redevelopment of the Mill Centre shopping centre.

“The subgroup have made great efforts to work in partnership with the owner of the Mill Centre, the council and local community to achieve the aim of retaining the services that the community have identified as much needed assets for the area and will continue to provide updates to the BFG and the wider community,” Kirkbright added.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

40% of Brits ready to embrace pharmacy delivery service

Same-day delivery and real-time tracking could be key to winning over consumers skeptical about pharmacy delivery service A survey...

PDA opposes DiCE guidance on online prescribing for GLP-1 agonist

PDA has withheld its endorsement of the DiCE guidance due to concerns over patient safety The Pharmacist's Defence Association...

Locum Pharmacist acquires 30-hour Moorside Pharmacy

The new owner plans to run Moorside Pharmacy on a hands-on basis and introduce additional services for the...

Breakthrough: Cabotegravir shows 88% reduction in HIV-1 incidence

Recommended by NICE and approved by the MHRA, Cabotegravir 600 mg long-acting injection is the first injectable treatment...